Pencor Dosage & Drug Information

Concise Prescribing Info

Contents

Doxazosin mesylate

Indications/Uses

HTN & benign prostatic hyperplasia (BPH).

Dosage/Direction for Use

HTN Initially 1 mg, may be increased if necessary. Max: 16 mg. BPH Initially 1 mg once daily. Recommended dose: 2-4 mg. Max: 8 mg.

Administration

May be taken with or without food.

Contraindications

Hypersensitivity to quinolones.

Special Precautions

Postural hypotension/syncope; use w/ PDE-5 inhibitors; impaired liver function. Pregnancy & lactation.

Adverse Reactions

Dizziness, vertigo, arrhythmias, dyspnea, orthostatic hypotension, priapism, headache, unusual tiredness, nausea & nervousness.

View ADR Monitoring Form

Drug Interactions

PDE-5 inhibitors.

MIMS Class

Drugs for Bladder & Prostate Disorders / Other Antihypertensives

ATC Classification

C02CA04 - doxazosin ; Belongs to the class of alpha-adrenoreceptor antagonists, peripherally-acting antiadrenergic agents. Used in the treatment of hypertension.

Regulatory Classification

Presentation/Packing

Form

Pencor tab 4 mg

Packing/Price

10 × 10's

Pencor

doxazosin

Manufacturer:

Unison

Distributor:

Medispec